In addition, recent research has indicated that the expression of FOXD1 is increased in glioma, while its inhibition decreases cell viability and migration and promotes cell senescence in the human glioblastoma cell line (Gao et al. 2017). Here, FOXD1 is linked to central nervous system cancer.